These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29172786)

  • 1. The Relationship Between Plasma Concentrations of Lutein and Zeaxanthin with Self-Reported and Actual Prevalence of AMD in an Irish Population-Based Sample.
    Moran R; Beatty S; Stack J; O'Halloran AM; Feeney J; Akuffo KO; Peto T; Kenny RA; Nolan JM
    Curr Eye Res; 2018 Mar; 43(3):383-390. PubMed ID: 29172786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-Dietary Correlates and Determinants of Plasma Lutein and Zeaxanthin Concentrations in the Irish Population.
    Moran R; Nolan JM; Stack J; O'Halloran AM; Feeney J; Akuffo KO; Kenny RA; Beatty S
    J Nutr Health Aging; 2017; 21(3):254-261. PubMed ID: 28244563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmentation of macular pigment following supplementation with all three macular carotenoids: an exploratory study.
    Connolly EE; Beatty S; Thurnham DI; Loughman J; Howard AN; Stack J; Nolan JM
    Curr Eye Res; 2010 Apr; 35(4):335-51. PubMed ID: 20373901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intakes of Lutein, Zeaxanthin, and Other Carotenoids and Age-Related Macular Degeneration During 2 Decades of Prospective Follow-up.
    Wu J; Cho E; Willett WC; Sastry SM; Schaumberg DA
    JAMA Ophthalmol; 2015 Dec; 133(12):1415-24. PubMed ID: 26447482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of daily intake of lutein+zeaxanthin, serum concentration of lutein/zeaxanthin and lipids profile between age-related macular degeneration patients and controls].
    Huang FF; Lin XM
    Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Apr; 46(2):237-41. PubMed ID: 24743813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of HDL-related loci with age-related macular degeneration and plasma lutein and zeaxanthin: the Alienor study.
    Merle BM; Maubaret C; Korobelnik JF; Delyfer MN; Rougier MB; Lambert JC; Amouyel P; Malet F; Le Goff M; Dartigues JF; Barberger-Gateau P; Delcourt C
    PLoS One; 2013; 8(11):e79848. PubMed ID: 24223199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of macular carotenoids in relation to age-related maculopathy: the Muenster Aging and Retina Study (MARS).
    Dasch B; Fuhs A; Schmidt J; Behrens T; Meister A; Wellmann J; Fobker M; Pauleikhoff D; Hense HW
    Graefes Arch Clin Exp Ophthalmol; 2005 Oct; 243(10):1028-35. PubMed ID: 15909159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum and retinal responses to three different doses of macular carotenoids over 12 weeks of supplementation.
    Stringham JM; Stringham NT
    Exp Eye Res; 2016 Oct; 151():1-8. PubMed ID: 27426932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary lutein, zeaxanthin, and fats and the progression of age-related macular degeneration.
    Robman L; Vu H; Hodge A; Tikellis G; Dimitrov P; McCarty C; Guymer R
    Can J Ophthalmol; 2007 Oct; 42(5):720-6. PubMed ID: 17724493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study.
    Trieschmann M; Beatty S; Nolan JM; Hense HW; Heimes B; Austermann U; Fobker M; Pauleikhoff D
    Exp Eye Res; 2007 Apr; 84(4):718-28. PubMed ID: 17306793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma Lutein, a Nutritional Biomarker for Development of Advanced Age-Related Macular Degeneration: The Alienor Study.
    Merle BMJ; Cougnard-Grégoire A; Korobelnik JF; Schalch W; Etheve S; Rougier MB; Féart C; Samieri C; Delyfer MN; Delcourt C
    Nutrients; 2021 Jun; 13(6):. PubMed ID: 34203817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships of Macular Pigment Optical Density With Plasma Lutein, Zeaxanthin, and Diet in an Elderly Population: The Montrachet Study.
    Alassane S; Binquet C; Cottet V; Fleck O; Acar N; Daniel S; Delcourt C; Bretillon L; Bron AM; Creuzot-Garcher C
    Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):1160-7. PubMed ID: 26975027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macular response to supplementation with differing xanthophyll formulations in subjects with and without age-related macular degeneration.
    Thurnham DI; Nolan JM; Howard AN; Beatty S
    Graefes Arch Clin Exp Ophthalmol; 2015 Aug; 253(8):1231-43. PubMed ID: 25311651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between intermediate age-related macular degeneration and lutein and zeaxanthin in the Carotenoids in Age-related Eye Disease Study (CAREDS): ancillary study of the Women's Health Initiative.
    Moeller SM; Parekh N; Tinker L; Ritenbaugh C; Blodi B; Wallace RB; Mares JA;
    Arch Ophthalmol; 2006 Aug; 124(8):1151-62. PubMed ID: 16908818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive Function and Its Relationship with Macular Pigment Optical Density and Serum Concentrations of its Constituent Carotenoids.
    Kelly D; Coen RF; Akuffo KO; Beatty S; Dennison J; Moran R; Stack J; Howard AN; Mulcahy R; Nolan JM
    J Alzheimers Dis; 2015; 48(1):261-77. PubMed ID: 26401946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lutein, Zeaxanthin and Meso-zeaxanthin Supplementation Associated with Macular Pigment Optical Density.
    Ma L; Liu R; Du JH; Liu T; Wu SS; Liu XH
    Nutrients; 2016 Jul; 8(7):. PubMed ID: 27420092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28.
    Chew EY; Clemons TE; Agrón E; Domalpally A; Keenan TDL; Vitale S; Weber C; Smith DC; Christen W;
    JAMA Ophthalmol; 2022 Jul; 140(7):692-698. PubMed ID: 35653117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationships between macular pigment optical density and its constituent carotenoids in diet and serum.
    Nolan JM; Stack J; O'connell E; Beatty S
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):571-82. PubMed ID: 17251452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum response to supplemental macular carotenoids in subjects with and without age-related macular degeneration.
    Meagher KA; Thurnham DI; Beatty S; Howard AN; Connolly E; Cummins W; Nolan JM
    Br J Nutr; 2013 Jul; 110(2):289-300. PubMed ID: 23211762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lutein and zeaxanthin status and risk of age-related macular degeneration.
    Gale CR; Hall NF; Phillips DI; Martyn CN
    Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2461-5. PubMed ID: 12766044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.